Clinical Trial Update: Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea [Phase 1, Phase 2]

View source ↗

Summary

The document reports Phase 1 and Phase 2 results for fecal microbiota transplantation to treat recurrent Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Recurrent C. Difficile Associated Diarrhea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-13